Journal Club 2026

Next HOPA Journal Club

Thursday, February 19, 2026 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Orange button that says click here to register

The moderator for February's Journal Club session is:

Samuel Schauer, PharmD, BCOP, UW Health, University of Madison, Madison, WI

February's Journal Club presenters include:

Thuy Huynh, PharmD

PGY2 Oncology Pharmacy Resident

Baptist Memorial Health Care, Memphis, TN

Article:

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

Reshma Patel, PharmD

PGY2 Oncology Pharmacy Resident

Northside Hospital, Atlanta, GA

Article:

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma

Featured Articles

The numbers 2025 with images of HOPA Hill Day and HOPA Annual Conference filling in the space

Membership

As 2026 Forges Ahead, A Look Back at HOPA in 2025

January 22, 2026

2025 certainly brought challenges both new and familiar to HOPA, our members, our patients, and those dear to them. But it's also brought hope. It's brought progress. And it's brought an inspiring sense of purpose, passion, and community.

Nurse sitting in hospital hallway resting against a wall

None

Proposed Student Loan Limits for Nursing and Other Professions Will Contribute to Healthcare Worker Shortages

January 16, 2026

HOPA is concerned about the Department of Education's proposed language and student loan limits for professions crucial to oncology care, especially nursing. Implementation will contribute to the shortage of healthcare workers in this country.

A line of women with breast cancer ribbons on their chests

Tools and Resources

Pharmacist's Application to Practice: Imlunestrant

January 08, 2026

Chan Tae Park, PharmD, PGY1 Pharmacy Resident, and Andrew Li, PharmD, BCOP, Oncology Pharmacist, dig into the potential role of imlunestrant (Inluriyo) in treating ESR1-mutated advanced/metastatic ER+, HER2- breast cancer.